-
Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
Schetters, S. T. T., Rodriguez, E., Kruijssen, L. J. W., Crommentuijn, M. H. W., Boon, L., van den Bossche, J., den Haan, J. M. M. & van Kooyk, Y., 19 Jul 2020, In: Journal for immunotherapy of cancer. 8, 2, 2020000588.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
